Client Background
Our Client is a Global Leader in Women's Health & Diagnostic Innovation
With a strong presence in North America, Europe, and Asia-Pacific, the client is renowned for transforming healthcare with innovative medical technologies. Their focus includes breast and skeletal health, diagnostics, and gynecologic surgical solutions, empowering clinicians with tools for early detection, accurate diagnosis, and minimally invasive treatment. Committed to advancing research, promoting health equity, and expanding access to care, the client continues to shape a healthier future for women globally through innovation and strategic collaboration.

Challenge
Evaluating market opportunity for next-gen surgical devices in AUB treatment
To assess the market potential for next-gen minimally invasive surgical devices for Abnormal Uterine Bleeding (AUB) treatment in India, we conducted primary research with gynecologists, sales reps, and distributors. This included evaluating treatment practices, awareness, adoption, pricing, and procurement behaviors. The study identified adoption barriers and key decision-making factors. Findings were compiled into a qualitative market landscape, supported by a quantitative demand model, to guide strategic launch planning and market entry.

Healthark’s role
Delivered Market Opportunity Assessment & Go-to-Market Strategy
Healthark conducted comprehensive primary research, market modeling, and strategic analysis to identify growth opportunities and guide the client’s product launch in India’s AUB surgical device market.
- Primary Market Research & Stakeholder Interviews
We conducted in-depth primary interviews with 30 gynecologists across Tier 1 cities in India, supplemented by 16 discussions with sales representatives & regional distributors. These interviews provided detailed insights into current clinical practices for managing abnormal uterine bleeding (AUB), levels of awareness & usage of surgical interventions, pricing sensitivity, & key barriers to adoption. This firsthand input was critical in understanding the dynamics of the Indian market from the perspective of both clinical & commercial stakeholders. - Market Sizing & Revenue Forecasting Model We developed a comprehensive quantitative model to estimate the total addressable market for advanced tissue removal devices & radiofrequency ablation devices used in AUB surgical treatments in India. This model combined primary research insights from gynecologists, sales representatives, & distributors with secondary data on procedure volumes, device usage patterns, & healthcare infrastructure. The model segmented the market into two key components: revenue from capital equipment (installed devices) & recurring revenue from consumables.
- Insights Synthesis & Strategic Recommendations Our integrated analysis culminated in a detailed insights synthesis outlining the market opportunity landscape, adoption challenges, & stakeholder expectations. Based on these findings, we developed strategic recommendations focused on engagement strategies, pricing considerations, & collaboration opportunities. These insights supported the client in refining their go-to-market strategy & aligning internal stakeholders on the path to a successful product launch in the Indian market.

Empowering Tomorrow's Healthcare
This case study showcases how Healthark’s market assessment and forecasting model enabled the client to identify revenue opportunities and refine their India entry strategy for AUB surgical devices. By combining primary and secondary research, we delivered actionable insights on adoption barriers, stakeholder needs, and regional dynamics, positioning the client for a successful, impactful product launch.